Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$2.835 7.79%
Market Cap
$178.2M
Price Target
Refer to Report
Volume
102.2K
52wk Range
$0.6101 - $4.22
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.